| 000 | 00978nam a22002777a 4500 | ||
|---|---|---|---|
| 001 | 06131 | ||
| 003 | HDC | ||
| 007 | cr bn ---aaaaa | ||
| 008 | 210123b20072007xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9780849398087 | ||
| 040 | _aHDC | ||
| 100 |
_aLyman, Michael D _eauthor _96441 |
||
| 245 | 0 |
_aPharmaceutical diversion _c/ Michael D. Lyman |
|
| 260 |
_aUnited States: _bTaylor & Francis, _c2007 |
||
| 300 | _a1 online resource (24 pages) | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 500 | _aOriginally from: Practical drug enforcement, 2007 (pages 211-234) | ||
| 650 |
_aDrug traffic _xInvestigation _zUnited States _96442 |
||
| 650 |
_aPharmaceutical industry _9799 |
||
| 856 | _zRequest full-text at [email protected] | ||
| 942 | _2lcc | ||
| 942 | _cCHAP | ||
| 942 | _kEBCH 004207 | ||
| 999 |
_c3455 _d3455 |
||